Based on the Wall Street analyst consensus for 193 of NL:SBIO’s holdings.
NL:SBIO 12 Month Forecast
Average Price Target
$88.28▲(0.00% Upside)
Based on Wall Street analyst 12-month price targets for 193 of Invesco NASDAQ Biotech UCITS ETF’s holdings in the last 3 months. The average price target is $88.28 with a high forecast of $113.64 and a low forecast of $65.51. The average price target represents a ― change from the last price of ―.
What is NL:SBIO’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 193 of NL:SBIO’s holdings, Invesco NASDAQ Biotech UCITS ETF’s 12-month average price target is $88.28.
Is NL:SBIO a Buy, Sell or Hold?
Invesco NASDAQ Biotech UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 193 of NL:SBIO’s holdings: 163 rated Buy, 29 rated Hold and 1 rated Sell.
What is Invesco NASDAQ Biotech UCITS ETF’s price target?
The average price target for Invesco NASDAQ Biotech UCITS ETF is $88.28, based on Wall Street analyst 12-month price targets for 193 of NL:SBIO’s holdings, issued in the past 3 months. The highest price target is $113.64 and the lowest is $65.51.
How many holdings does NL:SBIO have?
NL:SBIO holds 268 assets.
How can I buy shares of NL:SBIO?
You can buy shares of NL:SBIO through a brokerage account. Compare brokers on our Best Online Brokers page.